These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10773494)

  • 1. Effect of some psychotropic drugs and a barbiturate on mycoplasmas.
    Lind K; Kristiansen JE
    Int J Antimicrob Agents; 2000 Apr; 14(3):235-8. PubMed ID: 10773494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro modulation of human neutrophil chemotaxis by cis(Z)- and trans(E)-clopenthixol, and chlorpromazine.
    Rechnitzer C; Kristiansen JE; Kharazmi A
    Acta Pathol Microbiol Immunol Scand C; 1985 Oct; 93(5):199-203. PubMed ID: 4083016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antibacterial effect of selected phenothiazines and thioxanthenes on slow-growing mycobacteria.
    Kristiansen JE; Vergmann B
    Acta Pathol Microbiol Immunol Scand B; 1986 Dec; 94(6):393-8. PubMed ID: 3105243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The susceptibility of Plasmodium falciparum in vitro to chlorpromazine and the stereo-isomeric compounds cis(Z)- and trans(E)-clopenthixol.
    Kristiansen JE; Jepsen S
    Acta Pathol Microbiol Immunol Scand B; 1985 Jun; 93(3):249-51. PubMed ID: 3898718
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Waites KB; Crabb DM; Xiao L; Duffy LB
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum to clinafloxacin, PD 131628, ciprofloxacin and comparator drugs.
    Cohen MA; Huband MD
    J Antimicrob Chemother; 1997 Aug; 40(2):308-9. PubMed ID: 9302005
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in genital samples collected over 6 years at a Serbian university hospital.
    Skiljevic D; Mirkov D; Vukicevic J
    Indian J Dermatol Venereol Leprol; 2016; 82(1):37-41. PubMed ID: 26728808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum.
    Waites KB; Duffy LB; Bébéar CM; Matlow A; Talkington DF; Kenny GE; Totten PA; Bade DJ; Zheng X; Davidson MK; Shortridge VD; Watts JL; Brown SD
    J Clin Microbiol; 2012 Nov; 50(11):3542-7. PubMed ID: 22915608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereo-isomeric dissociation of the antibacterial and the neuroleptic effect of clopenthixol.
    Kristiansen JE; Mortensen I
    Acta Pathol Microbiol Scand B; 1981 Dec; 89(6):437-8. PubMed ID: 6121444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Antibiotic Susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in Pregnant Women.
    Lee MY; Kim MH; Lee WI; Kang SY; Jeon YL
    Yonsei Med J; 2016 Sep; 57(5):1271-5. PubMed ID: 27401661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frequency and antibiotic resistance of Ureaplasma urealyticum and Mycoplasma hominis in genital samples of sexually active individuals].
    Farkas B; Ostorházi E; Pónyai K; Tóth B; Adlan E; Párducz L; Marschalkó M; Kárpáti S; Rozgonyi F
    Orv Hetil; 2011 Oct; 152(42):1698-702. PubMed ID: 21979223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activities of investigational peptide deformylase inhibitor NVP LBM-415 and other agents against human mycoplasmas and ureaplasmas.
    Waites KB; Reddy NB; Crabb DM; Duffy LB
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2541-2. PubMed ID: 15917568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of mycoplasmas to antimicrobial agents: clinical implications.
    McCormack WM
    Clin Infect Dis; 1993 Aug; 17 Suppl 1():S200-1. PubMed ID: 8399916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
    Rylander M; Hallander HO
    Scand J Infect Dis Suppl; 1988; 53():12-7. PubMed ID: 2843982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ureaplasma urealyticum and Mycoplasma hominis susceptibility to antimicrobial agents.
    Marekovic I; Matesa S; Skerk V; Begovac J; Tambic-Andrasevic A; Skerk V
    J Chemother; 2007 Aug; 19(4):465-6. PubMed ID: 17855195
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the Etest for susceptibility testing of Mycoplasma hominis and Ureaplasma urealyticum.
    Dósa E; Nagy E; Falk W; Szöke I; Ballies U
    J Antimicrob Chemother; 1999 Apr; 43(4):575-8. PubMed ID: 10350390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative activity of minocycline and doxycycline on mycoplasmas pathogenic for man].
    Bebear C; Cantet P; Renaudin H; Quentin C
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):577-80. PubMed ID: 3937130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro activity of sparfloxacin against mycoplasmas].
    Renaudin H; Bebear C
    Pathol Biol (Paris); 1992 May; 40(5):450-4. PubMed ID: 1323094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in female outpatients, 2009-2013.
    Wang QY; Li RH; Zheng LQ; Shang XH
    J Microbiol Immunol Infect; 2016 Jun; 49(3):359-62. PubMed ID: 25081985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in-vitro activity of levofloxacin, other fluoroquinolones, doxycycline and erythromycin against Ureaplasma urealyticum and Mycoplasma hominis.
    Ullmann U; Schubert S; Krausse R
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():33-6. PubMed ID: 10404335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.